Once you see the results in your own patients, from complex cataracts to ‘straightforward cases,’ it’s hard to imagine looking a patient in the eye and offering anything else.
When I say to patients ‘the Light Adjustable Lens is the most precise implant on Mother Earth and, for the first time in history, we can truly customize your implant...in your eye,’ they get it and want it.
RxSight’s Light Adjustable Lens is the biggest improvement in cataract surgery in my career. We can now deliver the highest level of vision to our patients, tailored to their needs.
I love RxSight and the Light Adjustable Lens, and I’m thrilled to be using the technology. With the LAL, my toughest to please patients have become my happiest. I’m so thankful you brought this to market.
The ability to change the shape of a lens to perfectly match the eye after healing has resulted in the most precise results I have ever seen!
80% of our first 200 LAL patients saw 20/20 or better at both distance and near without glasses. As the LAL also provides the least amount of glare and halos, this makes the LAL the most accurate AND best quality IOL in the world today.
A link will be delivered to your email address that provides a download of the RxSight LAL Guide for Healthcare Professionals. If you don't receive anything, please be sure to check your junk or spam inbox.
The ability to treat 0.50 D of postoperative cylinder makes the RxSight LAL the only IOL in the United States approved to correct this level of vision-altering astigmatism.
Astigmatism of as little as 0.50 D can reduce visual acuity by one line, and the impact on dynamic, functional visual acuity and low-contrast acuity is even greater.
These percentages are results from the pivotal studies for each lens. The Tecnis toric lens was studied in a prospective, multicenter, two-armed, bilateral study of four Tecnis toric models in 269 patients. The primary effectiveness endpoint was the mean percent reduction in cylinder. The safety and effectiveness of the AcrySof toric lens were studied in a randomized clinical study of three models (SA60TT) and a control lens (SA60AT) in 421 patients.
92% of eyes (N = 391) achieved results within 0.50 D of target manifest refraction spherical equivalent (MRSE).
Patients are approximately two times more likely to achieve 20/20 vision or better without glasses at 6 months.
The study was a prospective, controlled, multicenter, 12-month study of 600 patients (ITT population) randomized to receive implantation with the RxSight LAL (N = 403) or a commercially available monofocal IOL (N = 197). Effectiveness analyses included 391 LAL patients and 193 control patients. Primary safety variables included best spectacle-corrected visual acuity (BSCVA) at 6 months and incidence of sight-threatening complications and adverse events. Primary effectiveness variables included percent reduction in manifest cylinder at 6 months, percent mean absolute reduction in MRSE at 6 months, and rotation of meridian of LAL at 6 months. Percent of eyes with an uncorrected visual acuity (UCVA) of 20/20 or better at six months post-operatively compared between the LAL treatment group and the monofocal control group was a secondary endpoint.
LAL patients saw nearly as well without glasses (UCVA) as control patients did with glasses (BCVA).
Since the LAL is a monofocal lens, there is low risk of dysphotopsias caused by splitting light, leading to enhanced vision and patient satisfaction.
We will connect with you shortly. We appreciate your interest in RxSight!
The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. RxSight does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to RxSight. Click “Continue” to leave site or “Return to RxSight.com” to close this window and return to RxSight.com.
The list of healthcare providers on the “Find a Physician” webpage is intended for informational purposes only and in no way represents an endorsement, referral, or recommendation from RxSight. The list is merely a tool to help identify certified and trained RxSight Light Adjustable Lens providers, and no compensation has been received or paid in exchange for listing the healthcare providers.
Selection of a healthcare provider is the patient’s responsibility and should be made with careful consideration. RxSight makes no representations or warranties and assumes no liability resulting from patient’s selection of a healthcare provider.